gadolinium dtpa has been researched along with Pseudomyxoma Peritonei in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alzate, GD; Barone, RM; Lacey, C; Low, RN; Sebrechts, CP; Sigeti, JS | 1 |
1 other study(ies) available for gadolinium dtpa and Pseudomyxoma Peritonei
Article | Year |
---|---|
Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
Topics: Administration, Oral; Barium Sulfate; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Glucagon; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Peritoneal Neoplasms; Prospective Studies; Pseudomyxoma Peritonei; Sensitivity and Specificity; Tomography, X-Ray Computed | 1997 |